Abstract
With the ever-increasing interest in minimally invasive cosmetic procedures and the growing non-Caucasian population of the USA, demand for research in photorejuvenation for darker skin tones is high. Lasers, specifically, have progressed tremendously in the last 20 years, becoming more elegant, efficient, and most of all, safer for all skin tones. They are no longer reserved just for fair skin, and can safely and effectively treat the ailments of individuals with dark skin. The use of lasers and light sources for pigmentation is generally based on wavelengths targeting melanin or pigment as the chromophore. Patients with darker skin tones present a challenge because light therapies are limited by their potential to cause postinflammatory dyspigmentation. Any therapy resulting in robust inflammation may induce this unwanted response. Although oftentimes temporary, postinflammatory hyperpigmentation may persist for many months, oftentimes becoming even more pronounced when approaches are taken to treat it. Strict perioperative use of topical bleaching agents and sun-protective measures are valuable in optimizing outcomes. Inciting factors such as sun exposure and other topicals need to be identified and discontinued to prevent further dyspigmentation during and after surgical treatment. Test spotting a representative lesion 4 weeks before treating the entire area is always recommended.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ortonne JP, Pandya AG, Lui H, Hexsel D. Treatment of solar lentigines. J Am Acad Dermatol. 2006;54(5 Suppl 2):S262–S271.
Stern RS, Dover JS, Levin JA, Arndt KA. Laser therapy versus cryotherapy of lentigines: a comparative trial. J Am Acad Dermatol. 1994;30(6):985–987.
Farris PK. Combination therapy for solar lentigines. J Drugs Dermatol. 2004;3(5 Suppl):S23–S26.
Chan HH. Effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses. Lasers Surg Med. 2005;37(3):179–185.
Chan HH, Kono T. The use of lasers and intense pulsed light sources for the treatment of pigmentary lesions. Skin Therapy Lett. 2004;9(8):5–7.
. Chan H. The use of lasers and intense pulsed light sources for the treatment of acquired pigmentary lesions in Asians. In: J Cosmet Laser Ther. 2003:198-200.
Lee PK, Rosenberg CN, Tsao H, Sober AJ. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol. 1998;38(2 Pt 2):314–317.
Downs AM, Rickard A, Palmer J. Laser treatment of benign pigmented lesions in children: effective long-term benefits of the Q-switched frequency-doubled Nd:YAG and long-pulsed alexandrite lasers. Pediatr Dermatol. 2004;21(1):88–90.
Shimbashi T, Kamide R, Hashimoto T. Long-term follow-up in treatment of solar lentigo and cafe-au-lait macules with Q-switched ruby laser. Aesthetic Plast Surg. 1997;21(6):445–458.
Kono T, Manstein D, Chan HH, Nozaki M, Anderson RR. Q-switched ruby versus long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. Lasers Surg Med. 2005;38(2):94–97.
Kono T, Chan HH, Groff WF, et al. Long-pulse pulsed dye laser delivered with compression for treatment of facial lentigines. Dermatol Surg. 2007;33(8):945–950.
Chan HH, Fung WK, Ying SY, Kono T. An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in Oriental patients. Dermatol Surg. 2000;26(8):743–749.
Kawada A, Shiraishi H, Asai M, et al. Clinical improvement of solar lentigines and ephelides with an intense pulsed light source. Dermatol Surg. 2002;28(6):504–508.
Kono T, Groff WF, Sakurai H, et al. Comparison study of intense pulsed light versus a long-pulse pulsed dye laser in the treatment of facial skin rejuvenation. Ann Plast Surg. 2007;59(5):479–483.
Li YT, Yang KC. Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines. Dermatol Surg. 1999;25(3):202–204.
Grossman MC, Anderson RR, Farinelli W, Flotte TJ, Grevelink JM. Treatment of cafe au lait macules with lasers. A clinicopathologic correlation. Arch Dermatol. 1995;131(12):1416–1420.
Kilmer SL, Garden JM. Laser treatment of pigmented lesions and tattoos. Semin Cutan Med Surg. 2000;19(4):232–244.
Carpo BG, Grevelink JM, Grevelink SV. Laser treatment of pigmented lesions in children. Semin Cutan Med Surg. 1999;18(3):233–243.
Acland KM, Barlow RJ. Lasers for the dermatologist. Br J Dermatol. 2000;143(2):244–255.
Alster TS, Williams CM. Cafe-au-lait macule in type V skin: successful treatment with a 510 nm pulsed dye laser. J Am Acad Dermatol. 1995;33(6):1042–1043.
Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. N Engl J Med. 1994;331(26):1745–1750.
Kono T, Chan HH, Ercocen AR, et al. Use of Q-switched ruby laser in the treatment of nevus of ota in different age groups. Lasers Surg Med. 2003;32(5):391–395.
Kang W, Lee E, Choi GS. Treatment of Ota’s nevus by Q-switched alexandrite laser: therapeutic outcome in relation to clinical and histopathological findings. Eur J Dermatol. 1999;9(8):639–643.
Chan HH, Ying SY, Ho WS, Kono T, King WW. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755 nm alexandrite and Q-switched 1064 nm Nd:YAG lasers in the treatment of nevus of Ota. Dermatol Surg. 2000;26(10):919–922.
Chan HH, Leung RS, Ying SY, et al. A retrospective analysis of complications in the treatment of nevus of Ota with the Q-switched alexandrite and Q-switched Nd:YAG lasers. Dermatol Surg. 2000;26(11):1000–1006.
Chan HH, Leung RS, Ying SY, Lai CF, Chua J, Kono T. Recurrence of nevus of Ota after successful treatment with Q-switched lasers. Arch Dermatol. 2000;136(9):1175–1176.
Hori Y, Takayama O. Circumscribed dermal melanoses. Classification and histologic features. Dermatol Clin. 1988;6(2):315–326.
Lam AY, Wong DS, Lam LK, Ho WS, Chan HH. A retrospective study on the efficacy and complications of Q-switched alexandrite laser in the treatment of acquired bilateral nevus of Ota-like macules. Dermatol Surg. 2001;27(11):937–941; discussion 41-42.
Polnikorn N, Tanrattanakorn S, Goldberg DJ. Treatment of Hori’s nevus with the Q-switched Nd:YAG laser. Dermatol Surg. 2000;26(5):477–480.
Kunachak S, Leelaudomlipi P. Q-switched Nd:YAG laser treatment for acquired bilateral nevus of ota-like maculae: a long-term follow-up. Lasers Surg Med. 2000;26(4):376–379.
Manuskiatti W, Sivayathorn A, Leelaudomlipi P, Fitzpatrick RE. Treatment of acquired bilateral nevus of Ota-like macules (Hori’s nevus) using a combination of scanned carbon dioxide laser followed by Q-switched ruby laser. J Am Acad Dermatol. 2003;48(4):584–591.
Ee HL, Goh CL, Khoo LS, Chan ES, Ang P. Treatment of acquired bilateral nevus of ota-like macules (Hori’s nevus) with a combination of the 532 nm Q-Switched Nd:YAG laser followed by the 1,064 nm Q-switched Nd:YAG is more effective: prospective study. Dermatol Surg. 2006;32(1):34–40.
Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131(12):1453–1457.
Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol. 1986;15(4 Pt 2):894–899.
Fitzpatrick RE, Goldman MP, Ruiz-Esparza J. Laser treatment of benign pigmented epidermal lesions using a 300 nsecond pulse and 510 nm wavelength. J Dermatol Surg Oncol. 1993;19(4):341–347.
Grekin RC, Shelton RM, Geisse JK, Frieden I. 510-nm pigmented lesion dye laser. Its characteristics and clinical uses. J Dermatol Surg Oncol. 1993;19(4):380–387.
Goldberg DJ. Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser. J Dermatol Surg Oncol. 1993;19(4):376–379.
Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol. 1994;20(9):592–597.
Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25(2):121–123.
Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg. 2003;29(1):59–64.
Fisher GH, Geronemus RG. Short-term side effects of fractional photothermolysis. Dermatol Surg. 2005;31(9 Pt 2):1245–1249; discussion 9.
Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34(5):426–438.
Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg. 2005;31(12):1645–1650.
Tannous ZS, Astner S. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma. J Cosmet Laser Ther. 2005;7(1):39–43.
Atkin DH, Fitzpatrick RE. Laser treatment of imipramine-induced hyperpigmentation. J Am Acad Dermatol. 2000;43(1 Pt 1):77–80.
Karrer S, Hohenleutner U, Szeimies RM, Landthaler M. Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. Arch Dermatol. 1999;135(3):251–253.
Green D, Friedman KJ. Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature. J Am Acad Dermatol. 2001;44(2 Suppl):342–347.
Becker-Wegerich PM, Kuhn A, Malek L, Lehmann P, Megahed M, Ruzicka T. Treatment of nonmelanotic hyperpigmentation with the Q-switched ruby laser. J Am Acad Dermatol. 2000;43(2 Pt 1):272–274.
Friedman IS, Shelton RM, Phelps RG. Minocycline-induced hyperpigmentation of the tongue: successful treatment with the Q-switched ruby laser. Dermatol Surg. 2002;28(3):205–209.
Alster TS, Gupta SN. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser. Dermatol Surg. 2004;30(9):1201–1204.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
Ke, M.S. (2009). Lasers and Light Therapies for Pigmentation. In: Baron, E. (eds) Light-Based Therapies for Skin of Color. Springer, London. https://doi.org/10.1007/978-1-84882-328-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-84882-328-0_7
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-327-3
Online ISBN: 978-1-84882-328-0
eBook Packages: MedicineMedicine (R0)